These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33282864)

  • 21. CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation.
    Chang TT; Yang HY; Chen C; Chen JW
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
    Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zhx2 Accelerates Sepsis by Promoting Macrophage Glycolysis via Pfkfb3.
    Wang Z; Kong L; Tan S; Zhang Y; Song X; Wang T; Lin Q; Wu Z; Xiang P; Li C; Gao L; Liang X; Ma C
    J Immunol; 2020 Apr; 204(8):2232-2241. PubMed ID: 32179636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shear stress-induced atherosclerotic plaque composition in ApoE(-/-) mice is modulated by connexin37.
    Pfenniger A; Meens MJ; Pedrigi RM; Foglia B; Sutter E; Pelli G; Rochemont V; Petrova TV; Krams R; Kwak BR
    Atherosclerosis; 2015 Nov; 243(1):1-10. PubMed ID: 26342936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia.
    Wang L; Cao Y; Gorshkov B; Zhou Y; Yang Q; Xu J; Ma Q; Zhang X; Wang J; Mao X; Zeng X; Su Y; Verin AD; Hong M; Liu Z; Huo Y
    Pharmacol Res; 2019 Aug; 146():104292. PubMed ID: 31167111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heme oxygenase-1 inhibits progression and destabilization of vulnerable plaques in a rabbit model of atherosclerosis.
    Li T; Tian H; Zhao Y; An F; Zhang L; Zhang J; Peng J; Zhang Y; Guo Y
    Eur J Pharmacol; 2011 Dec; 672(1-3):143-52. PubMed ID: 22004613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase D3 promotes gastric cancer development through p65/6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 activation of glycolysis.
    Zhang J; Zhang Y; Wang J; Zhang S; Zhao Y; Ren H; Chu Y; Feng L; Wang C
    Exp Cell Res; 2019 Jul; 380(2):188-197. PubMed ID: 31026442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Local Macrophage Growth Ameliorates Focal Inflammation and Suppresses Atherosclerosis.
    Yamada S; Senokuchi T; Matsumura T; Morita Y; Ishii N; Fukuda K; Murakami-Nishida S; Nishida S; Kawasaki S; Motoshima H; Furukawa N; Komohara Y; Fujiwara Y; Koga T; Yamagata K; Takeya M; Araki E
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):994-1006. PubMed ID: 29496659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss.
    Wang J; Guan H; Liu H; Lei Z; Kang H; Guo Q; Dong Y; Liu H; Sun Y; Fang Z; Li F
    J Cell Mol Med; 2020 Feb; 24(3):2294-2307. PubMed ID: 31880389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.
    Hans CP; Zerfaoui M; Naura AS; Troxclair D; Strong JP; Matrougui K; Boulares AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):150-8. PubMed ID: 19124646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.
    Cao Y; Zhang X; Wang L; Yang Q; Ma Q; Xu J; Wang J; Kovacs L; Ayon RJ; Liu Z; Zhang M; Zhou Y; Zeng X; Xu Y; Wang Y; Fulton DJ; Weintraub NL; Lucas R; Dong Z; Yuan JX; Sullivan JC; Meadows L; Barman SA; Wu C; Quan J; Hong M; Su Y; Huo Y
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13394-13403. PubMed ID: 31213542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia.
    Xu J; Wang L; Yang Q; Ma Q; Zhou Y; Cai Y; Mao X; Da Q; Lu T; Su Y; Bagi Z; Lucas R; Liu Z; Hong M; Ouyang K; Huo Y
    Front Cardiovasc Med; 2021; 8():745810. PubMed ID: 34660743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
    Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
    Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD70 limits atherosclerosis and promotes macrophage function.
    Winkels H; Meiler S; Smeets E; Lievens D; Engel D; Spitz C; Bürger C; Rinne P; Beckers L; Dandl A; Reim S; Ahmadsei M; Van den Bossche J; Holdt LM; Megens RT; Schmitt M; de Winther M; Biessen EA; Borst J; Faussner A; Weber C; Lutgens E; Gerdes N
    Thromb Haemost; 2017 Jan; 117(1):164-175. PubMed ID: 27786334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
    Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
    J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of mTOR by lentivirus‑mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E‑deficient mice.
    Wang X; Li L; Li M; Dang X; Wan L; Wang N; Bi X; Gu C; Qiu S; Niu X; Zhu X; Wang L
    Int J Mol Med; 2013 Nov; 32(5):1215-21. PubMed ID: 24043133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. eNOS-Nitric Oxide System Contributes to a Novel Antiatherogenic Effect of Leonurine via Inflammation Inhibition and Plaque Stabilization.
    Ning K; Wang MJ; Lin G; Zhang YL; Li MY; Yang BF; Chen Y; Huang Y; Li ZM; Huang YJ; Zhu L; Liang K; Yu B; Zhu YZ; Zhu YC
    J Pharmacol Exp Ther; 2020 Jun; 373(3):463-475. PubMed ID: 32238453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.